6 Sep 2019 15:25
Notification and public disclosure of transactions by person discharging managerial responsibilities
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Said Darwazah |
2 | Reason for the notification | |
a) | Position/status | Executive Chairman |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Disposal of 150,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by Banque Lombard Odier & Cie SA |
c) | Price(s) and volume(s) | Price(s): £20.56 Volume(s): 49,826 Price(s): £19.85 Volume(s): 25,000 Price(s): £19.82 Volume(s): 25,000 Price(s): £19.84 Volume(s): 25,000 Price(s): £19.82 Volume(s): 25,174 |
d) | Aggregated information | Aggregated volume: 150,000 Price: £20.07 Total: £3,011,121 |
e) | Date of the transaction | 4 and 6 September 2019 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Peter Speirs, Company Secretary, Responsible for releasing this announcement
6 September 2019
Hikma Pharmaceuticals (HIK)